Assessing cutaneous malignancy risk in hidradenitis suppurativa: A case-control analysis from the All of us research program

Authors

  • Malak Husseinali School of Medicine, Baylor College of Medicine, Houston, TX, USA Author
  • Tiffany Mayo Dchool of Medicine, Baylor College of Medicine, Houston, TX, USA Author

DOI:

https://doi.org/10.25251/8eqvkz83

Keywords:

autoinflammatory disease, basal cell carcinoma, cohort study, hidradenitis suppurativa, melanoma, risk factors, ss

Abstract

 

References

Abu Rached N, Rüth J, Gambichler T, Ocker L, Bechara FG. A state-of-the-art systematic review of cancer in hidradenitis suppurativa. Ann Med. 2024;56:2382372. [PMID: 39046819].

Lapins J, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol. 2001;137:730-4. [PMID: 11405761].

Martora F, Tommasino N, Battista T, Potestio L, Megna M. Hidradenitis suppurativa cancer risk: a review of the literature. Clin Cosmet Investig Dermatol. 2025;18:617-26. [PMID: 40124933].

All of Us Research Program Investigators, Denny JC, Rutter JL, et al. The “All of Us” Research Program. N Engl J Med. 2019;381:668-76. [PMID: 31412182].

Downloads

Published

05/09/2026

Data Availability Statement

Data used in this study are available as a featured workspace to registered researchers of the All of Us Research Program.

Issue

Vol. 32 No. 2 (2026): Dermatology Online Journal

Section

Letter

License

Copyright (c) 2026 Malak Husseinali, Tiffany Mayo (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.